60% of high-priority research goes unfunded.
There are 3 types of vaccines to protect against HPV infection in Canada – Cervarix, Gardasil and Gardasil 9. HPV vaccines do not treat HPV infections you already have or treat diseases or cancers associated with HPV.
Cervarix protects females against HPV types 16 and 18. Because Cervarix protects against 2 types of infection, it is called a bivalent vaccine. Cervarix does not protect against genital warts.
Gardasil protects males and females against 2 types of low-risk HPV that cause genital warts (types 6 and 11) and 2 types of high-risk HPV that cause cancer (types 16 and 18). Because Gardasil protects against 4 types of infection, it is called a quadrivalent vaccine.
Gardasil 9 protects males and females against 2 types of low-risk HPV that cause genital warts (types 6 and 11) and 7 types of high-risk HPV that cause cancer (types 16, 18, 31, 33, 45, 52 and 58). Because Gardasil 9 protects against 9 types of infection, it is called a nonavalent vaccine.
HPV vaccines have been approved and recommended by Health Canada and the National Advisory Committee on Immunization (NACI). Health Canada approves vaccines based on their effectiveness and safety, while NACI provides recommendations for how the vaccines should best be used to prevent disease.
All provinces and territories have publicly funded, school-based HPV vaccination programs for girls 9 to 13 years of age (grades 4 to 8). Many vaccination programs also include boys.